Cyclo Therapeutics (CYTHW) Competitors

$0.22
-0.05 (-18.52%)
(As of 04/22/2024)

CYTHW vs. ALVOW, BFRIW, CLVRW, PROCW, SBFMW, GCAN, ATNFW, SXTPW, ACONW, and AIMDW

Should you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include Alvotech (ALVOW), Biofrontera (BFRIW), Clever Leaves (CLVRW), Procaps Group (PROCW), Sunshine Biopharma (SBFMW), Greater Cannabis (GCAN), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), and Ainos (AIMDW). These companies are all part of the "medical" sector.

Cyclo Therapeutics vs.

Cyclo Therapeutics (NASDAQ:CYTHW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

In the previous week, Cyclo Therapeutics' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Cyclo Therapeutics Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
Cyclo TherapeuticsN/A N/A N/A
Alvotech N/A N/A N/A

Cyclo Therapeutics and Alvotech both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Cyclo TherapeuticsN/AN/A
AlvotechN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyclo Therapeutics$1.08MN/AN/AN/AN/A
Alvotech$91.43MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cyclo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Alvotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Alvotech beats Cyclo Therapeutics on 1 of the 1 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYTHW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYTHW vs. The Competition

MetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.18B$4.65B$7.58B
Dividend YieldN/A3.02%5.35%3.94%
P/E RatioN/A1,000.74233.7619.10
Price / SalesN/A8,612.382,323.1587.44
Price / CashN/A9.9444.8135.27
Price / BookN/A4.104.624.48
Net IncomeN/A$105.19M$98.41M$211.90M
7 Day PerformanceN/A1,669.05%114.21%3.92%
1 Month Performance-7.72%1,801.98%108.99%-3.25%
1 Year Performance-22.81%1,994.71%136.17%7.21%

Cyclo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVOW
Alvotech
0 of 5 stars
$3.22
-5.3%
N/A+117.3%$0.00$91.43M0.00999Gap Down
BFRIW
Biofrontera
0 of 5 stars
$0.06
+22.2%
N/A-80.3%$0.00$34.07M0.0083Gap Up
CLVRW
Clever Leaves
0 of 5 stars
$0.04
flat
N/A-27.6%$0.00$17.42M0.00296Gap Down
PROCW
Procaps Group
0 of 5 stars
$0.05
flat
N/A-82.9%$0.00$414.10M0.005,500Short Interest ↓
SBFMW
Sunshine Biopharma
0 of 5 stars
$0.05
-28.6%
N/A-84.8%$0.00$24.09M0.0044Gap Down
High Trading Volume
GCAN
Greater Cannabis
0 of 5 stars
$0.00
flat
N/A+0.0%$0.00N/A0.001
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-41.5%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.09
-18.2%
N/AN/A$0.00$253,573.000.002Gap Down
ACONW
Aclarion
0 of 5 stars
$0.03
flat
N/A-46.2%$0.00$75,404.000.004Gap Down
AIMDW
Ainos
0 of 5 stars
$0.08
flat
N/AN/A$0.00$122,112.000.0046

Related Companies and Tools

This page (NASDAQ:CYTHW) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners